Preventive Effect of Naringin on Metabolic Syndrome and Its Mechanism of Action: A Systematic Review

Abstract EN

Background.

Metabolic syndrome (MetS), which consists of cluster of conditions, hypertension, hyperlipidemia, hyperglycemia, and visceral obesity, is affecting population worldwide.

Studies have shown that plant derived flavonoids have the ability to alleviate MetS.

Naringin is a type of glycoside flavonoid found in most plant and it plays a critical role in the treatment of MetS due to its antioxidant activity and ability to regulate cytokines.

Methods.

A systematic review was done to study the effects of naringin on the metabolic diseases using electronic databases which include Ovid and Scopus using specific descriptors published from the year 2010 till present to provide updated literature on this field.

The articles were assessed and chosen based on the criteria in which the mechanisms and effects of naringin on different metabolic diseases were reported.

Results.

Thirty-four articles were identified which referred to the studies that correspond to the previously stated criteria.

Subsequently after screening for the articles that were published after the year 2010, finally, 19 articles were selected and assessed accordingly.

Based on the assessment, naringin could alleviate MetS by reducing visceral obesity, blood glucose, blood pressure, and lipid profile and regulating cytokines.

Conclusions.

Naringin is an antioxidant that appears to be efficacious in alleviating MetS by preventing oxidative damage and proinflammatory cytokine release.

However, the dosage used in animal studies might not be achieved in human trials.

Thus, adequate investigation needs to be conducted to confirm naringin’s effects on humans.